IIf you compare the same peptide across different listings, the prices can vary quite a bit. But the vial price alone doesn't always explain the difference. For example: 5 mg at $35 = $7.00 per mg 10 mg at $50 = $5.00 per mg The $35 listing has the lower upfront price, but the $50 listing has the lower price per mg. That's why we look beyond the headline price when analyzing peptide pricing. Quantity, price per mg, current pricing, and available testing documentation can all add useful context. Price per mg doesn't tell you which product or supplier is “better.” It's simply a way to normalize pricing when quantities are different. We're going to explore more pricing patterns like this inside the Peptide Grading community. What do you usually look at first when comparing listings: total price, price per mg, or testing/COA information?